Compstatin control peptide acetate
CAS No. 301544-78-5
Compstatin control peptide acetate( —— )
Catalog No. M37918 CAS No. 301544-78-5
Compstatin control peptide acetate is an inhibitor of complement protein C3 by binding and inhibiting the cleavage of complement C3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 287 | Get Quote |
|
| 5MG | 432 | Get Quote |
|
| 10MG | 629 | Get Quote |
|
| 25MG | 908 | Get Quote |
|
| 50MG | 1260 | Get Quote |
|
| 100MG | 1665 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCompstatin control peptide acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCompstatin control peptide acetate is an inhibitor of complement protein C3 by binding and inhibiting the cleavage of complement C3.
-
DescriptionCompstatin control peptide is a negative control of Compstatin (HY-P1036). Compstatin is a potent complement system C3 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetComplement System
-
RecptorComplement System
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number301544-78-5
-
Formula Weight1488.65
-
Molecular FormulaC66H101N23O17
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 25 mg/mL (16.79 mM; Ultrasonic)
-
SMILESCC[C@H](C)[C@@H](C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](Cc1c[nH]c2c1cccc2)C(NCC(N[C@@H](Cc1c[nH]cn1)C(N[C@@H](Cc1c[nH]cn1)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@@H]([C@@H](C)O)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sahu A, et al. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J Immunol. 2000 Sep 1;165(5):2491-9.?
molnova catalog
related products
-
Leukadherin 1
Leukadherin 1 (LA1) is a small molecule allosteric agonist of integrin CD11b/CD18 (CR3).
-
Avacopan
Avacopan (CCX-168, CCX168) is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM.
-
Sutimlimab
Sutimlimab is a novel monoclonal antibody targeting complement protein C1. Sutimlimab is commonly used as a C1 inhibitor to treat cold agglutina-associated hemolysis.
Cart
sales@molnova.com